StockWatch
·
HomeLiveReports
Tea & Coffee
Board Meeting23 Oct 2026, 06:10 pm

Novyra Pharmachem Ltd Board Meeting on Nov 2, 2026

AI Summary

Novyra Pharmachem Ltd has announced that its Board of Directors will convene on November 2, 2026. The primary agenda item is the consideration and approval of the Unaudited Financial Results for the second quarter ended September 30, 2026, along with the Auditor's Limited Review Report. The meeting will also address any other business as permitted by the Chairman.

Key Highlights

  • Board meeting scheduled for November 2, 2026.
  • To consider Unaudited Financial Results for Q2 FY27.
  • Auditor's Limited Review Report to be presented.
  • Other business may be discussed with Chairman's permission.
View BSE Filing
BANSTEA
Tea & Coffee
BANSISONS TEA INDUSTRIES LTD.

Price Impact

More from BANSTEA

Insider Trading25 Sept, 5:11 pm

Novyra Pharmachem Closes Trading Window for Q2 FY27 Results

Corporate Governance24 Sept, 10:16 pm

Novyra Pharmachem Changes Official Email ID

Rebranding22 Aug, 2:31 pm

Bansisons Tea Industries Renamed Novyra Pharmachem Limited

More in Board Meeting

SUMEETINDS43m ago

Sumeet Industries Board Meeting on Oct 31 to Approve Un-Audited Financials

ELECTHERM43m ago

Electrotherm Board Meeting on Nov 4 to Approve Q2 FY27 Results

SHIVKAMAL44m ago

Shivkamal Impex Board Meeting on Oct 31 for Unaudited Results